English 中文版
Clinical Center
Medical Oncology
Surgery
Gynecologic Oncology
Traditional Chinese Medicine/Integrative Oncology
Radiation Oncology
Anesthesiology
Medical Laboratory

Contact Us

Tel: +86-731-88651900

Fax: +86-731-88651999

Mail: hnszlyy_network@163.com

Add: 283 Tongzipo Road, Yuelu District, Changsha, 410013, Hunan, P.R. China

Urology Surgery Department Home > Departments > SURGERY > Urology Surgery Department

Introduction

Since the seventies of the last century-the beginning of the establishment of the hospital, the Urology Surgery Department of Hunan Cancer Hospital has been comprehensively carrying out the surgical diagnosis and treatment work on genitourinary malignancies. In this way, the department has accumulated rich experiences, established and formed a genitourinary malignancies diagnosis and treatment system. Under the leadership of the director, Han Weiqing, the Urology Surgery Department has developed into a well-known urinary male reproductive tumor center where medication, teaching, and scientific research are integrated. Targeted at international first-class treatment concepts, the department has set up the sub -professional groups dealing with kidney tumor, bladder cancer, prostate cancer, male reproductive system tumors and so on, engaging in accurate diagnosis and treatment of cancers. It has become one of the largest male genitourinary cancer diagnosis and treatment centers in the central-south region with medical technology reaching the international advanced level.


The contemporary medicine recognizes that individualized treatment and MDT (Multiple Disciplinary Team) should be adopted while sticking to the principle of cancer treatment so that the best treatment results can be reached while the quality of life can be guaranteed. All these can’t happen without advanced examination means and comprehensive treatments. The department has reached a domestic and international advanced level in treating rare, complex, terminal and refractory urinary tumors owing to the various internationally advanced medical equipment and a full set of cancer treatment methods of the Hospital, including chemotherapy, radiotherapy, Chinese medicine treatment, interventional treatment, cryotherapy, radiofrequency ablation, biological therapy, immunologic therapy, molecular targeted therapy, radioisotope treatment, and thermotherapy, etc.


The hospital boasts of various examination equipment and detecting methods of an internationally advanced level, such as PET-CT, intraluminal ultrasound, CT, MRI, modular biology, genetic testing and immunologic test equipment, cytological examination equipment and a full set of male reproductive cancer examination equipment. All of these have provided a solid ground for cancer screening, early diagnosing and accurate stage judgment, as well as provided a guarantee on individualized comprehensive treatment and efficacy for patients.


To treat male reproductive cancers, the department has been adhering to the cancer treatment principles, i.e. the tumor free principle, the radical principle and the comprehensive treatment principle, formulating specific treatment protocols for patients in line with the latest international treatment standard. And it chooses the appropriate surgery method by making full use of the respective advantages of open surgery and endoscopic surgery. In addition to carrying out a variety of conventional genitourinary tumor radical surgery and surgical procedure, the minimally invasive treatment technology has also been widely used, such as laparoscopic technology, resectoscope technology and 3D printing technology. The department regularly carries out urological oncology surgery with high difficulties, including radical cystectomy, radical prostatectomy, radical nephrectomy, thrombectomy of the inferior vena cava tumor thrombus, retroperitoneal lymph node dissection (RPLND), resection of the complicated adrenal pheochromocytoma, salvage lymphadenectomy of large metastasis inguinal lymph node and ureter vesicovaginal fistula repair. The treatment effect of malignant tumors is closely related to the cutting scope of the primary lesion and the handling quality of relevant lymph nodes. Therefore, the department not only emphasizes the routinely lymph node treatment technique, but also performs expanded lymph node dissection, sentinel lymph node biopsy (SLNB) according to the specific patient condition.


Major breakthroughs in the development of minimally invasive technique and new techniques, it pays attention to the functional conservation and reconstruction with the treatment effect guaranteed. The department performs partial nephrectomy with laparoscopic nephron sparing surgery, laparoscopic 3D printing assisted nephron sparing surgery on renal hilar tumor, and laparoscopic neurovascular bundle sparing radical cystectomy to protect the patients’ sexual function. The Orthotopic neobladder after radical cystectomy is carried out to retain urinary function and avoid the impact of stoma on the quality of life; the laparoscopic nerve sparing radical prostatectomy radical cystectomy is performed to retain patients’ sexual function; the salvage lymphadenectomy of large metastasis inguinal lymph node and skin flap repair are combined with some large - scale complicated surgeries such as the extensive resection of groin flap transfer, the first and second phase of reconstruction of penis, and penis lengthening surgery; the treatment effect is further improved by ureteral metal stent implantation, neoadjuvant radio (chemo-) therapy and interventional treatment, radioactive seed implantation, drug infusion and cryotherapy. The development of new technologies has attracted physicians from all over the country to visit and study.


In treating advanced cancer, the department carries out postoperative comprehensive treatments including radiotherapy, chemotherapy, interventional therapy, brachy-therapy, cryotherapy, radiofrequency ablation and targeted drug therapy, etc., providing new choices for patients inoperable or unwilling to adopt surgery treatment to get a good therapeutic effect. The department has taken an initial action to employ the BCG bladder instillation to treat high-risk bladder cancer, achieving good results.


Relying on the national clinical pharmacology base, the department launches a number of global drug clinical trials, providing patients with cancer with the best drug treatment, enabling terminal patients to embrace new hope.


The department focuses on fostering talents. Several staff has been sent to learn and exchange experiences in American, German and large domestic medical centers. Each year, several staff will be sent to give lectures and share our experiences in cancer treatment in the international and domestic large conferences. The department is equipped with two sets of imported ultra-high-definition laparoscopic equipment, and two sets of imported resectoscopes and cystoscopes, one exclusively possessed flexible cystoscope within Hunan province, 2 sets of ureteroscopes, and ultrasonic scalpel, ligsure, PK scalpel, energy platform, intraoperative b-mode ultrasound, intraoperative X- ray device, etc.

Doctors
Contact
Address: 15F Building 1
Tel: 89762270
Related
News
Newsroom
Notice
Videos
International
Clinical Service
Departments
Find a Doctor
Experts
Request an Appointment
Research & Education
Cancer Research
Clinical Trials
Selected Publications
Graduate Education
Resident Training
Download Center
Nursing
Nursing
About us
Introduction
Leadership
Contact
Q&A